Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOMILNACIPRAN vs LEVOSULPIRIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOMILNACIPRAN vs LEVOSULPIRIDE: Safety Overview

Metric LEVOMILNACIPRAN LEVOSULPIRIDE
Total FAERS Reports 1,378 177
Deaths Reported 382 8
Death Rate 27.7% 4.5%
Hospitalizations 378 73
Average Patient Age 46.4 yrs 57.3 yrs
% Female Patients 80.2% 57.4%
FDA Approval Date Feb 4, 2019 N/A
Manufacturer Allergan, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A